Navigation Links
VBI awarded $27 million from NIH to support infectious disease research
Date:10/5/2009

dle the designated bacterial data in the context of infectious diseases the change in scale of data acquisition and analysis is astonishing and we are poised to learn a lot."

The new contract covers the development of two web-based resources for biomedical research. The first part of the project supports the development of the Pathogen Portal for the entire BRC program. The Pathogen Portal will serve as an informatics coordinating center and gateway for the four newly established BRCs. This publicly accessible web portal will provide general information about the BRC program, serve as a gateway to the individual BRC web sites, and provide a central data repository and analysis resource for all selected NIAID category A-C priority pathogens supported by the individual BRCs. Said Sobral, "In addition to its centralized coordination role, the Pathogen Portal project will work closely with other external partners, for example NIAID's Clinical Proteomics Centers for Infectious Diseases and Biodefense, among others, which is making candidate protein biomarkers linked to disease available to the wider scientific community."

The second part of the project supports the development of the PATRIC 2.0 BRC. In June 2004, NIAID awarded CIG a five-year, $10.3 million contract to establish a multi-organism relational database for infectious disease research that focused on biodefense and emerging infectious diseases. The PathoSystems Resource Integration Center (PATRIC; see http://patric.vbi.vt.edu/) was created to serve as a comprehensive web-based resource for an important subset of pathogens from the set of selected NIAID category A-C priority pathogens. The work supported by the PATRIC 2.0 award, which will span all bacterial species in the selected NIAID category A-C priority pathogens list, will consolidate earlier PATRIC work, as well as the work of other BRC systems that handled bacterial data, into PATRIC 2.0.
'/>"/>

Contact: Barry Whyte
whyte@vbi.vt.edu
540-231-1767
Virginia Tech
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. UNC awarded Cancer Genome Atlas grant
2. 2 neuroscientists from Cold Spring Harbor Laboratory awarded transformative NIH grants
3. IOF-AMGEN Health Professional Awareness Grants awarded at Beijing conference
4. Prestigious $4.9 million NIH grant awarded to Case Western Reserve for colon cancer research
5. UA awarded $4.35 million to study Earths critical zone
6. Researcher awarded $1.2 million grant to study centrosomes and cilia
7. Barrow scientist awarded $400,000 grant to study cell associated with intuition and autism
8. IGC scientist awarded prestigious European Research Council Starting grant
9. LSUHSCs Bazan awarded ARRA grant to preserve vision
10. UTSA psychologist awarded $1 million for memory research
11. LSUHSCs Kolls awarded $1.8 million to improve vaccine strategies for P. carinii pneumonia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...hers are invited to contribute their abstracts to ...ECCEO10), the largest global meeting devoted to al...rch and patient care. The Congress will be held in... today, abstracts can be submitted online at http...dline is February 4, 2010. , IOF and ESCEO are p...
(Date:11/20/2009)...y question in the origin of biological molecules l...llions of years ago from simple precursors. Now, i...s in Italy have reconstructed one of the earliest ...RNA from individual subunits using nothing but war...s one of the first biological molecules present, b...
(Date:11/20/2009)...Toxic dust: Toxins in coal-tar-based sealcoats in ...use dust, according to a USGS study. PAHs or pol... found in oil, coal and tar deposits, and can have... often found in house dust; however, the specific ...searchers found that dust from indoor areas near p...
Breaking Biology News(10 mins):Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Immune responses to flu vaccine are diminished in lupus patients 53173 1Immune responses to flu vaccine are diminished in lupus patients 53173 2Nanoparticle delivered suicide genes slowed ovarian tumor growth 9423 1Nanoparticle delivered suicide genes slowed ovarian tumor growth 9423 2Reducing risk of hospitalization in the elderly 9421 1Reducing risk of hospitalization in the elderly 9421 2
... To arrange for an interview with a researcher, p...tions staff member identified at the end of each t...and development activities, please refer to one of...elated question or comment, you can send it to ne... . . , Oak Ridge National Laboratory researcher...
... Barcelona, Spain: It is better for children conc...igins at an early age, according to the first larg...or conception. If the children are not told until ... feelings of shock and anger, the 24th annual meet...and Embryology in Barcelona heard today (Monday). ...
... , , ARTICLE #1 FOR IMMEDIATE RELEASE , Boosti... Diabetes, Bioconjugate Chemistry , Researchers...rove the effectiveness and expand the use of trans...s. Their study is scheduled for the July 16 issue ...l. Insulin-dependent, or Type 1, diabetes affects ...
Other Biology News:Story tips from the Department of Energy's Oak Ridge National Laboratory, July 2008 2Story tips from the Department of Energy's Oak Ridge National Laboratory, July 2008 3Children born after donor insemination should be told as soon as possible about their conception 2Children born after donor insemination should be told as soon as possible about their conception 3American Chemical Society's Weekly PressPac -- July 2, 2008 2American Chemical Society's Weekly PressPac -- July 2, 2008 3American Chemical Society's Weekly PressPac -- July 2, 2008 4American Chemical Society's Weekly PressPac -- July 2, 2008 5American Chemical Society's Weekly PressPac -- July 2, 2008 6American Chemical Society's Weekly PressPac -- July 2, 2008 7American Chemical Society's Weekly PressPac -- July 2, 2008 8American Chemical Society's Weekly PressPac -- July 2, 2008 9
(Date:11/19/2009)..., BLAUVELT, N.Y., Nov. 19 Dr. Mat... extract, responds to a press release issued on No...arian company for making false and self-serving st...ences. ,, Dr. Hidvegi stated from his office i...that research on Avemar does not apply to AveULTRA...
(Date:11/19/2009)... , MUNSTER, Germany, November 19 /PRNewswir...ve filed on November 16th, 2009 Flibanserin in the...skinesia in Parkinson,s,disease for orphan drug st...y,(EMEA). Levodopa-induced dyskinesia is a complic...son,s and a serious burden to some of those,affect...
(Date:11/19/2009)... , VIENNA, Austria, November 19 /PRNewswir...e program on one product candidate at an unexpecte...ate AD02 is planned to enter into,Phase II clinica...y,immediately follows the completion of two Phase ...mpany based its fast decision on the first interim...
(Date:11/18/2009)...ists at Queen,s University Belfast are developing ...drugs which will help in the fight against the thr... special gel pads to ,swipe, an individual or crim...by a scanning instrument that can detect the prese...etter, faster decisions to be made in response to ...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New technology detects chemical weapons in seconds 2
... Feb. 26 BioVascular, Inc., a company focused,on ...ated diseases, today,announced that it appointed C... vice president of pharmaceutical operations and E...usiness development and nonvascular,operations., ...and experience to,BioVascular that will allow us t...
...Calif., Feb. 26 Ardea Biosciences,Inc. (Nasdaq: ...atory,disease Scientific Advisory Board (SAB). The...d counsel to the Company regarding key decisions,r...o treat chronic,inflammatory diseases, such as gou...ether a group of international authorities in gout...
... Industry Veteran to Head Rapid Sales Growth of Le...ement Developer, SANTA CLARA, Calif., Feb. 26 Ek...l radiography (DR), PACS (Picture Archiving and,Co...are (VIA(TM)) for,veterinary care practices, today...resident of worldwide sales. Royea is a long-time ...
Other Biology Technology:BioVascular, Inc. Expands Executive Team 2Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program 2Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program 3Royea Joins Eklin Medical Systems as VP of Worldwide Sales 2Royea Joins Eklin Medical Systems as VP of Worldwide Sales 3
Complete 2 channel polarographic oxygen monitoring system from Instech Solomon
XTT (23-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) from Molecular Probes (Invitrogen)
...5) This volume provides excellent background inf...ds for the study of major HIV proteins including: ...uclease H, integrase and protease. Expression of H...s; Tat and Rev assays; HIV/CD4 interactions; trans...
Sheep Anti-Mouse TREM-2 Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: